Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 6Genitourinary 2CNS 2Other solid neoplasm 1Gynecologic 1Gastrointestinal 1

Conditions

Testicular Neoplasms 22Kidney Neoplasms 18Ovarian Neoplasms 17Testicular Germ Cell Tumor 16Urinary Bladder Neoplasms 14Wilms Tumor 13Sarcoma 13Teratoma 10Central Nervous System Neoplasms 10Neuroectodermal Tumors, Primitive, Peripheral 9Neuroblastoma 9Carcinoma, Renal Cell 9Prostatic Neoplasms 8Endodermal Sinus Tumor 8Seminoma 7Medulloblastoma 7Carcinoma, Embryonal 7Retinoblastoma 6Osteosarcoma 6Astrocytoma 6Ovarian Germ Cell Cancer 5Optic Nerve Glioma 5Neoplasm Metastasis 5Melanoma 5Lymphoma 5Recurrence 4Liver Neoplasms 4Head and Neck Neoplasms 4Familial ependymoma 4Dendritic Cell Sarcoma, Interdigitating 4

Interventions

X-Rays 4Phantoms, Imaging 4Cyclophosphamide 4Specimen Handling 3Melphalan 3Magnetic Resonance Spectroscopy 3Granulocyte Colony-Stimulating Factor 3Busulfan 3ulixertinib 2tipifarnib 2tazemetostat 2talazoparib 2selpercatinib 2palbociclib 2ivosidenib 2fludarabine 2cabozantinib 2Vemurafenib 2Topotecan 2Temozolomide 2Sirolimus 2Nuclear Medicine Department, Hospital 2Nivolumab 2LY3023414 2Filgrastim 2Bone Marrow Transplantation 2trioctyl phosphine oxide 1regorafenib 1racotumomab 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Filgrastim × Genitourinary × Clear all
NCT00638898 2025-03-20

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

City of Hope Medical Center

Phase 1 Completed
25 enrolled
CNSGenitourinarySarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Testicular Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma

NCT00003926 2017-11-29

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
13 enrolled
CNSGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcoma

Ovarian Germ Cell Cancer, Astrocytoma, Brain Neoplasms, Chordoma, Ependymoma, Glioma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Hepatoblastoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡